1 / 25

Tuberculosis

Tuberculosis. August 17, 2010. Tuberculosis. Mycobacterium tuberculosis Fastidious, aerobic, acid-fast bacillus Tremendous increase in incidence over 25 yrs On average, a dult pts infect 8 to 15 individuals prior to being diagnosed Increased risk HIV, diabetes, renal failure

piera
Download Presentation

Tuberculosis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Tuberculosis August 17, 2010

  2. Tuberculosis • Mycobacterium tuberculosis • Fastidious, aerobic, acid-fast bacillus • Tremendous increase in incidence over 25 yrs • On average, adult pts infect 8 to 15 individuals prior to being diagnosed • Increased risk • HIV, diabetes, renal failure • 9% of pts in US coinfected with HIV

  3. Three Groups • Exposed, but status unknown • Insufficient period of time to rely on TST • Latent TB Infection • Positive TST but no signs or symptoms, nl CXR • 30% global population • 5-10% progress to disease • TB Disease • Clinical or radiographic findings • Reportable

  4. Resistance • Drug-resistant TB (DR-TB) • Relapse after tx • Positive sputum smear after 2mos tx • Multidrug-resistant TB (MDR-TB) • Resistance to at least 2 first line abx (1% in US) • Extensively drug-resistant TB • Resistance to INH, rifampin, any fluoroquinolone, and any second line IV agent

  5. Pathogenesis • Lymphadenitis • Ghon complex • Focus of infection with enlarged regional nodes • Contained • Spread rapidly • Reactivated later in life • Most clinical manifestations in children 1-2 yrs from initial infection

  6. Clinical Manifestations • Lung is most common site of infxn (80%) • Tuberculous LAD (67%) • Meningitis (13%) • Most commonly infants and toddlers • Pleural, miliary, skeletal account for <6%

  7. Pulmonary Disease • Primary Parenchymal • Most common, Infants most likely to be symptomatic • Cough, low-grade fever, wt loss • CXR: hilar or mediastinaladenopathy • Collapse-consolidation pattern • Progressive Primary Disease • Lung tissue destruction and cavitary lesion • Reactivation disease • Immunocompromised adolescents or adults

  8. Lymphatic Disease • Most common extrapulmonary form of TB • Usually cervical nodes • Slightly older than pts with nontuberculousmycobacterial LAD • 2-4cm, may have overlying violaceous skin color • Lack classic findings of pyogenic nodes • CXR abnl in 33% • Tx: 6 mos multidrug tx, +/- excision

  9. CNS Disease • 50% are <2y/o • May include CNS vasculitis or increased ICP • Consider in cases of childhood stroke • Tuberculomas in 5% of CNS TB • Single rim-enhancing lesion • CSF: lymphocytes, low glucose, high protein • TST in only 33% • CXR in 90% • Highest morbidity/mortality

  10. Diagnosis • TST, epidemiologic info, clinical/radiographic findings • Children: vigorous response to few organisms • 30% with positive cx (AFB) • TST (purified protein derivative or Mantoux) • Read at 48-72hrs • Delayed hypersensitivity rxn in those exposed • Negative in 15% of cases • Interferon-gamma release assay (IGRA) • Use CXR, CT not routine

  11. Treatment • TB Exposure • Contact with index case, but asymptomatic, neg TST and CXR • If < 4y/o or immunocompromised • INH pending results of repeat TST (2-3 mos) • LTBI • INH for 9mos • If intermittently dosed, used Directly Observed Tx

  12. Treatment • TB Disease • 4 drug Directly Observed Therapy • INH, rifampin, pyrazinamide, ethambutol • 6 months • If CNS involvement, 9-12 mos

  13. What about infant of TB mom? • Maternal LTBI… no workup or isolation for infant • Maternal positive TST and CXR abnl but not consistent with TB • Maternal AFB sputum smear neg • No isolation or workup for infant • Tx maternal LTBI

  14. What about infant of TB mom? • Mom with CXR consistent with TB • Evaluate infant for TB • CXR and PE • If infant is normal • Separate from mother until she is being treated and infant starts INH • Once on INH, separation unnecessary and may breastfeed

  15. Health Care Workers • Positive TST with normal CXR • Offer therapy for LTBI • Repeat screening should be done with CXR, not TST

  16. Prevention • Negative pressure and N95 use in children • Cavitary or extensive pulmonary involvement • AFB positive TB • Procedures such as intubation/bronchoscopy • BCG vaccine in US • Children continually exposed to MDR-TB • Continually exposed to adults who have infectious TB who cannot be removed from setting

More Related